“EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION”, RJDNMD, vol. 31, no. 1, pp. 366–389, Feb. 2024, Accessed: May 18, 2024. [Online]. Available: https://jrdiabet.ro/index.php/RJDNMD/article/view/304